Clinical Trial Update: Preliminary Research On Two-step Dosing Of Imipenem/Cilastatin [Phase 4]

View source ↗

Summary

This clinical trial update describes preliminary research on a two-step dosing approach for Imipenem/Cilastatin in sepsis patients (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Imipenem/Cilastatin (imipenem/cilastatin)

Snippet

Sponsor: Southeast University, China | Conditions: Sepsis | Phase 4 | Status: UNKNOWN